The urgency underlying the work is difficult to overstate. Multidrug-resistant Gram-negative infections, methicillin-resistant Staphylococcus aureus, and hospital-acquired sepsis continue to claim lives at rates that conventional antibiotics struggle to contain. The World Health Organization has repeatedly flagged antibiotic resistance as one of the defining health crises of the century, and the problem is compounded by biofilms: organized communities of bacteria wrapped in a self-produced extracellular polymeric matrix that shields them from both immune attack and antimicrobial drugs. Biofilms colonize medical devices, implants, wounds, dental surfaces, water systems and food-processing equipment, and bacteria within them can exhibit tolerance levels hundreds to thousands of times higher than their free-floating counterparts. Traditional antibacterial approaches, the review argues, are increasingly outmatched by this dual threat of resistance and biofilm persistence.

Carbon dots offer a chemically distinctive answer. First reported in 2004 and popularized by seminal work on bright, quantum-sized photoluminescent carbon nanoparticles, these materials typically measure less than ten nanometers and consist of a carbonaceous core decorated with surface functional groups such as carboxyl, hydroxyl and amine moieties. Unlike semiconductor quantum dots containing cadmium or lead, carbon dots are generally built from benign, abundant precursors ranging from citric acid and urea to plant extracts, bacteria and food waste, giving them an environmental and biocompatibility profile that is difficult for heavy-metal nanomaterials to match. Their optical properties are equally compelling: strong fluorescence, tunable emission across the visible and near-infrared spectrum, high photostability, and in some cases room-temperature phosphorescence or aggregation-induced emission. The review contrasts these attributes with conventional semiconductor quantum dots and organic fluorescent dyes, finding carbon dots competitive or superior in biocompatibility, cost and functional versatility.

The mechanistic heart of the review dissects how carbon dots actually kill bacteria, grading the strength of evidence for each proposed pathway. The most thoroughly documented mechanism is the generation of reactive oxygen species. When photoexcited, carbon dots can transfer energy or electrons to oxygen molecules, producing singlet oxygen, superoxide, hydroxyl radicals and hydrogen peroxide through both type I and type II photodynamic pathways. These reactive species oxidize bacterial lipids, proteins and DNA, inflicting damage that is difficult for microbes to counter because it strikes multiple targets simultaneously rather than a single enzyme or receptor. Intersystem crossing and heteroatom doping, particularly with nitrogen, phosphorus or sulfur, tune the efficiency of this ROS production, and studies with chemiluminescent carbon nanodots have shown bacteria can be destroyed even by the dots’ own emitted light.

Physical disruption of the bacterial membrane constitutes a second major killing route. Bacterial surfaces carry a net negative charge, and carbon dots engineered with cationic groups, such as quaternary ammonium, guanidinium or polyamine functionalities, bind electrostatically to those surfaces, destabilizing the lipid bilayer and causing leakage of intracellular contents. Work on positively charged dots derived from tartaric acid and m-aminophenol demonstrated selective killing of Gram-positive bacteria, while super-cationic dots synthesized from spermidine have been formulated as eye drops to treat bacterial keratitis. Evidence also implicates interference with bacterial metabolism: carbon dots have been shown to inhibit enzymes central to glycolysis and peroxidase activity, induce lipid peroxidation measurable by malondialdehyde levels, promote programmed bacterial death, and even trigger transitions in DNA conformation. The review stresses that surface chemistry, not just particle size, is the dominant variable, a conclusion reinforced by quantitative structure-activity relationships that link surface functionalization directly to photo-activated antibacterial potency.

Against biofilms specifically, carbon dots deploy a layered strategy. Preventing initial adhesion is the first line of defense: negatively charged or amphiphilic dots can repel bacterial attachment to surfaces, and coatings incorporating carbon nanodots have produced antibiofilm and anticorrosion surfaces for industrial applications. Once a biofilm has formed, the extracellular polymeric matrix becomes the barrier, and carbon dots have demonstrated the ability to penetrate that matrix, imaging its scaffolds and, in quaternized variants, eradicating the embedded cells with enhanced efficiency. Perhaps most intriguingly, the review documents interference with quorum sensing, the chemical communication system bacteria use to coordinate biofilm formation and virulence. Carbon dots have disrupted acyl-homoserine lactone and autoinducing peptide signaling, undermined the machinery that coordinates collective behavior, and thereby prevented mature biofilm architecture from developing. Combined approaches, including carbon dots grafted with chitosan, papain, silver or gold nanoparticles, and metal-doped formulations using copper or iron, amplify these effects through synergistic oxidative and physical mechanisms.

Synthesis routes shape all of these properties, and the review systematically compares top-down methods, which cleave larger carbon structures such as graphite, carbon nanotubes or activated carbon via electrochemical oxidation, laser ablation or chemical oxidation, with bottom-up approaches that build dots from molecular precursors through hydrothermal, solvothermal, microwave or pyrolytic processing. Top-down routes often yield crystalline graphitic cores with robust photoluminescence, while bottom-up routes offer finer control over dopant incorporation and surface passivation. The choice of precursor, temperature, reaction time and dopant determines the emission color, surface charge, ROS-generating capacity and biocompatibility of the final product. Green synthesis from medicinal plants, sugarcane juice, ginkgo leaves and bacterial biomass has produced multifunctional dots with simultaneous antimicrobial, antioxidant and bioimaging capabilities, and particle size distribution itself has been shown to influence antibacterial strength.

The application landscape the review maps is strikingly broad. In biomedicine, carbon dots have treated infected wounds in hydrogels, eradicated biofilms on medical implants and titanium surfaces, combated bacterial keratitis and pneumonia, and shown low drug-resistance development over prolonged use, a critical advantage where conventional antibiotics rapidly select for resistant strains. In food science, carbon-dot-loaded films and coatings have preserved salmon, avocado and fresh produce by combining antibacterial action with UV shielding and antioxidant activity, while fluorescent aptamer-conjugated dots detect pathogens such as Salmonella and Escherichia coli with high sensitivity. Environmental and sensing applications range from wastewater-treatment membranes and photocatalytic pollutant degradation to fluorescence probes for toxic metal ions, pesticides, antibiotics and bacterial quorum-sensing activity, with emerging theranostic platforms integrating imaging, sensing and therapy in single nanomaterials.

The review does not shy away from the field’s weaknesses. Batch-to-batch consistency in large-scale production remains a persistent stumbling block, since minor variations in precursor composition or reaction conditions can shift surface chemistry and, with it, biological activity. Long-term in vivo biocompatibility and biodistribution data are still limited, and the stability of carbon dots in the complex chemical environments of real infections, wounds and industrial systems requires far more rigorous evaluation. Standardized protocols for characterizing and benchmarking antibacterial performance are also lacking, making cross-study comparisons difficult. Looking forward, the authors identify multifunctional theranostic carbon dots that combine diagnostics, drug delivery and phototherapy, along with structure-guided rational design driven by quantitative structure-activity relationships, as the most promising trajectories. If those challenges can be met, carbon dots may graduate from laboratory curiosity to frontline weapon in the escalating war against antibiotic-resistant bacteria and the biofilms that shelter them.

Subject of Research: Carbon dots as antibacterial and anti-biofilm nanomaterials

Article Title: Carbon dots: a promising antibacterial and anti-biofilm agent

Article References: Li, P., Zhang, S., Yu, X., Chen, J., Xu, Y., Zhang, D., Ke, X., & Li, Z. (2026). Carbon dots: a promising antibacterial and anti-biofilm agent. Journal of Nanoparticle Research, 28(9), Article 239. https://doi.org/10.1007/s11051-026-06759-y

Image Credits: AI Generated

DOI: 10.1007/s11051-026-06759-y

Keywords: carbon dots, antibacterial, anti-biofilm, reactive oxygen species, membrane disruption, quorum sensing, antibiotic resistance, nanomaterials, photodynamic therapy, biofilms, nanomedicine, green synthesis

Antibiotic resistance poses an existential threat to modern medicine, largely fueled by the dissemination of ARGs via plasmid conjugation. These plasmids, self-replicating DNA molecules, can transfer resistance determinants such as mcr-1, encoding colistin resistance; bla_NDM-1, responsible for carbapenem resistance; and tet(X4), associated with tigecycline resistance. Conventional inhibitors targeting conjugation often falter due to toxicity or diminished performance in physiological contexts, underscoring an urgent need for safe and potent alternatives. This study positions cinnamic acid (CA) as a compelling candidate, leveraging its natural abundance and established safety profile.

The research team meticulously evaluated CA’s inhibitory capacity against a spectrum of clinically relevant plasmid types, including IncP, IncI2, IncX4, IncHI2, and IncFII. Using bacterial cultures, they demonstrated that CA diminishes conjugation frequency in a concentration-dependent manner without impairing bacterial viability within tested concentrations. This selective inhibition is crucial as it prevents the propagation of resistance genes without disrupting beneficial microbial growth, preserving microbial ecosystem balance.

To simulate real-world complexity, the investigators employed a fluorescence-labeled plasmid tracking system to monitor ARG transfer within intestinal microbial consortia ex vivo. Their analyses confirmed that CA effectively suppresses plasmid conjugation in a natural microbial milieu, highlighting its translational potential. Extending these findings to living organisms, oral administration of CA in murine models resulted in a significant, dose-dependent decrease in in vivo plasmid transfer, demonstrating efficacy under physiological conditions.

At the molecular level, transcriptomic profiling elucidated the pathways affected by CA. The compound disrupts the tricarboxylic acid (TCA) cycle, a central metabolic hub, leading to impaired electron transport chain function and dissipation of the proton motive force. These perturbations cause a notable reduction in intracellular ATP levels, a vital energy currency necessary for the energy-intensive conjugation process. By draining the energy reservoir of donor bacteria, CA effectively stalls plasmid transfer machinery.

Moreover, gene expression analysis revealed that CA downregulates critical components of the mating pair formation apparatus and DNA transfer and replication systems. Intriguingly, CA modestly increases the permeability of the donor bacterial outer membrane, potentially facilitating a hostile environment for plasmid conjugation without inducing cytotoxicity. This multifaceted mechanism highlights CA’s unique approach—targeting bacterial energy metabolism and conjugation machinery simultaneously.

Safety evaluations in animal models demonstrated that CA administration produces no discernible adverse effects. Mice maintained stable body weight, exhibited no histopathological abnormalities in key organs, and preserved gut microbiota diversity and composition. These findings reinforce CA’s biosafety, rendering it an attractive candidate for in vivo applications aimed at mitigating the spread of antibiotic resistance without disrupting host homeostasis.

The implications of this study are profound. By leveraging a naturally occurring, dietary compound with dual conjugation inhibition mechanisms and a strong safety profile, this work lays the foundation for novel antimicrobial resistance containment strategies. CA offers a pragmatic adjunct to existing antibiotic stewardship efforts, potentially curbing the transfer of resistance traits in clinical, agricultural, and environmental settings.

Expanding on this research opens avenues for the design of metabolism-targeted conjugation inhibitors rooted in natural product chemistry. Such development aligns with a broader paradigm shift towards ecological and sustainable antimicrobial approaches. The prospect of harnessing food-derived compounds to modulate bacterial gene transfer marks a promising frontier in combating the escalating antibiotic resistance crisis.

Notably, this study exemplifies interdisciplinary collaboration encompassing microbiology, molecular biology, metabolism, and pharmacology. Integrating mechanistic insights with practical in vivo validation fortifies the translational impact of these findings. The researchers highlight the necessity of advancing clinical trials and ecological assessments to fully harness cinnamic acid’s potential as a conjugation inhibitor.

As antibiotic resistance continues to compromise infection control worldwide, innovative interventions like CA are urgently needed. This study positions cinnamic acid as a pioneering agent capable of disrupting the cycle of resistance dissemination at the molecular and community levels. By impeding plasmid conjugation—a prime vector of resistance gene flow—CA could become a keystone in the global endeavor to preserve antibiotic efficacy.

The full manuscript entitled “Targeting Plasmid Conjugation with Cinnamic Acid: A Novel Approach to Combat Antibiotic Resistance,” authored by Gong Li and colleagues, was published on February 17, 2026, in Engineering. The open access article details the intricate methodology, comprehensive analyses, and broader significance of this work. For scientists and healthcare professionals alike, these findings present a compelling new chapter in antimicrobial resistance research.

In summary, cinnamic acid emerges as a potent, safe, natural inhibitor of antibiotic resistance plasmid conjugation with a unique mode of action targeting bacterial energy metabolism and conjugation gene expression. Its application could revolutionize how horizontal gene transfer is controlled across diverse environments, offering hope in the escalating battle against multidrug-resistant pathogens.

Subject of Research: Inhibition of plasmid-mediated conjugation to combat antibiotic resistance using cinnamic acid.

Article Title: Targeting Plasmid Conjugation with Cinnamic Acid: A Novel Approach to Combat Antibiotic Resistance.

News Publication Date: 17-Feb-2026.

Web References:

• https://doi.org/10.1016/j.eng.2025.06.040
• https://www.sciencedirect.com/journal/engineering

Image Credits: Gong Li, Ang Gao et al.

Keywords: Antibiotic resistance, plasmid conjugation, horizontal gene transfer, cinnamic acid, antimicrobial resistance, metabolic inhibition, tricarboxylic acid cycle, electron transport chain, ATP depletion, bacterial energy metabolism, gene expression regulation, biosafety.